C

Cidara Therapeutics
D

CDTX

19.040
USD
-1.64
(-7.93%)
Market Closed
Volume
930
EPS
-19
Div Yield
-
P/E
-1
Market Cap
134,167,892
OverviewSignalsIdeasNews
Related Instruments
    AZN
    AZN
    -1.830
    (-2.81%)
    66.385 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    754.1 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    101.205 USD
    NVO
    NVO
    -3.620
    (-3.44%)
    104.55 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    103.54 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    26.16 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    462.07 USD
    More
News

Title: Cidara Therapeutics

Sector: Healthcare
Industry: Biotechnology
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak(R) platform targeting oncologic, viral and autoimmune diseases.